Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (181-190 of 273) with videos related to

Pageof 28
Sort By:
JAMA Oncology|December 7, 2018
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP GuidelinesMichael F Press, Jose A Seoane, Christina Curtis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control studySarah J Lord, Leslie Bernstein, Karen A Johnson, et al.
Scientific Reports|May 7, 2026
Expression of HER2 in the eye and the potential for on-target side effects with antibody-drug conjugatesSimon Davenport, Bin Xie, Kevin Hamblett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVEStephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Cancer Research|July 5, 2005
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imagingTove Olafsen, Vania E Kenanova, Gobalakrishnan Sundaresan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences StudyMichael S Simon, Jeannette F Korczak, Cecilia L Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2017
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVEStephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Nature Genetics|February 13, 1999
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomasC A Wilson, L Ramos, M R Villaseñor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 11, 2009
Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal womenChristopher I Li, Robert W Mathes, Kathleen E Malone, et al.
Breast Cancer Research : BCR|September 28, 2013
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black womenHuiyan Ma, Yani Lu, Polly A Marchbanks, et al.
Pageof 28

Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
JAMA Oncology|December 7, 2018
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP GuidelinesMichael F Press, Jose A Seoane, Christina Curtis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control studySarah J Lord, Leslie Bernstein, Karen A Johnson, et al.
Scientific Reports|May 7, 2026
Expression of HER2 in the eye and the potential for on-target side effects with antibody-drug conjugatesSimon Davenport, Bin Xie, Kevin Hamblett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVEStephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Cancer Research|July 5, 2005
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imagingTove Olafsen, Vania E Kenanova, Gobalakrishnan Sundaresan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences StudyMichael S Simon, Jeannette F Korczak, Cecilia L Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2017
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVEStephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Nature Genetics|February 13, 1999
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomasC A Wilson, L Ramos, M R Villaseñor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 11, 2009
Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal womenChristopher I Li, Robert W Mathes, Kathleen E Malone, et al.
Breast Cancer Research : BCR|September 28, 2013
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black womenHuiyan Ma, Yani Lu, Polly A Marchbanks, et al.
Pageof 28